Preoperative variables |
Stable group (n=258) |
Increasing-slow group(n=67) |
Increasing-fast
group(n=53) |
P-valve
|
Duration of medical history (months) |
69.00±82.77 |
143.32±115.34 |
147.98±151.41 |
<0.001 |
Age (years) |
48.74±9.18 |
54.78±7.29 |
56.30±6.71 |
<0.001 |
Female, n (%) |
58.53 |
77.61 |
83.02 |
<0.001 |
Body mass index (kg/m²) |
24.35±7.72 |
22.74±3.47 |
23.39±3.98 |
0.269 |
Systolic blood pressure (mmHg) |
123.13±18.09 |
124.25±19.68 |
122.57±18.83 |
0.869 |
Diastolic blood pressure (mmHg) |
82.36±11.85 |
83.64±9.127 |
85.53±11.83 |
0.103 |
Heart rate (bpm) |
77.34±12.04 |
76.94±13.28 |
74.92±11.93 |
0.645 |
Left ventricular ejection fraction (%) |
60.29±6.25 |
60.72±5.39 |
60.35±7.46 |
0.967 |
Atrial fibrillation, n (%) |
29.07 |
76.12 |
88.68 |
<0.001 |
Mild pulmonary arterial hypertension, n (%) |
10.47 |
68.66 |
88.68 |
<0.001 |
Left atrial diameter (mm) |
43.59±6.14 |
53.10±9.18 |
55.97±5.74 |
<0.001 |
Tricuspid regurgitation area(cm²) |
2.04±1.45 |
4.84±2.67 |
6.60±3.13 |
<0.001 |
Mitral regurgitation area(cm²) |
7.43±6.83 |
6.97±7.87 |
7.26±6.98 |
0.478 |
Right atrial transverse diameter (mm) |
39.99±5.92 |
48.41±8.14 |
51.46±6.14 |
<0.001 |
Right atrial longitudinal diameter (mm) |
47.25±6.34 |
55.54±7.49 |
59.70±6.01 |
<0.001 |
Left ventricular end diastolic diameter (mm) |
48.26±7.47 |
50.38±9.20 |
51.57±8.94 |
0.005 |
Left ventricular end systolic diameter (mm) |
32.73±7.79 |
31.57±7.09 |
33.65±9.19 |
0.243 |
Right ventricular dilation (mm) |
18.85±3.30 |
18.63±3.80 |
17.61±2.34 |
0.05 |
Pulmonary artery diameter (mm) |
25.18±4.99 |
25.458±5.66 |
24.52±5.51 |
0.791 |
Aspartate transaminase/alanine transaminase ratio |
1.21±0.65 |
1.37±0.91 |
1.46±0.84 |
0.088 |
Creatinine (umol/L) |
89.21±53.17 |
89.56±56.16 |
91.59±41.43 |
0.866 |
Blood urea nitrogen (mmol/L) |
7.69±3.65 |
6.891±2.74 |
8.61±2.74 |
0.163 |
NYHA classification, n (%) |
|
|
|
|
II |
37 |
12 |
8 |
0.897 |
III |
197 |
46 |
41 |
0.698 |
IV |
24 |
9 |
4 |
0.911 |